Enzalutamide for patients with metastatic castration-resistant prostate cancer.

Autor: Ramadan, Wijdan H.1 wramadan@lau.edu.lb, Kabbara, Wissam K.1, Hiba S. Al Basiouni Al Masri2
Zdroj: OncoTargets & Therapy. 2015, Vol. 8, p871-876. 6p.
Databáze: Academic Search Ultimate